Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 30% ± 12% | |
peripheral blood | 12 studies | 24% ± 6% | |
intestine | 10 studies | 26% ± 10% | |
kidney | 9 studies | 25% ± 5% | |
brain | 8 studies | 31% ± 8% | |
eye | 7 studies | 29% ± 15% | |
liver | 6 studies | 32% ± 16% | |
lymph node | 5 studies | 23% ± 6% | |
pancreas | 4 studies | 47% ± 15% | |
uterus | 4 studies | 38% ± 17% | |
breast | 4 studies | 24% ± 2% | |
bone marrow | 3 studies | 18% ± 1% | |
adrenal gland | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3346.20 | 459 / 459 | 100% | 116.08 | 1118 / 1118 |
liver | 100% | 3217.00 | 226 / 226 | 100% | 92.66 | 406 / 406 |
pancreas | 100% | 2075.08 | 328 / 328 | 100% | 67.31 | 178 / 178 |
brain | 100% | 2305.53 | 2639 / 2642 | 100% | 69.86 | 705 / 705 |
prostate | 100% | 3018.47 | 245 / 245 | 100% | 73.50 | 501 / 502 |
ovary | 100% | 2796.55 | 180 / 180 | 100% | 59.30 | 429 / 430 |
stomach | 100% | 2688.93 | 359 / 359 | 100% | 61.44 | 285 / 286 |
bladder | 100% | 2883.90 | 21 / 21 | 100% | 72.39 | 502 / 504 |
adrenal gland | 100% | 4986.35 | 258 / 258 | 100% | 67.00 | 229 / 230 |
thymus | 100% | 3860.92 | 653 / 653 | 100% | 60.03 | 602 / 605 |
lung | 100% | 2794.51 | 578 / 578 | 99% | 75.74 | 1149 / 1155 |
esophagus | 100% | 2761.64 | 1445 / 1445 | 99% | 59.22 | 182 / 183 |
kidney | 100% | 3325.84 | 89 / 89 | 99% | 59.08 | 895 / 901 |
skin | 100% | 3219.18 | 1809 / 1809 | 99% | 76.80 | 468 / 472 |
intestine | 100% | 3457.57 | 966 / 966 | 99% | 63.54 | 521 / 527 |
uterus | 100% | 2923.34 | 170 / 170 | 98% | 70.71 | 451 / 459 |
adipose | 100% | 3120.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2468.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.12 | 1 / 1 |
blood vessel | 100% | 3023.25 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1463.57 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1878.90 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 48.99 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 94% | 35.09 | 75 / 80 |
peripheral blood | 78% | 1560.17 | 726 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001503 | Biological process | ossification |
GO_0006983 | Biological process | ER overload response |
GO_0032469 | Biological process | endoplasmic reticulum calcium ion homeostasis |
GO_0160063 | Biological process | multi-pass transmembrane protein insertion into ER membrane |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0160064 | Cellular component | multi-pass translocon complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043022 | Molecular function | ribosome binding |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | TMCO1 |
Protein name | Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3) Calcium load-activated calcium channel (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1) Alternative protein TMCO1 Calcium load-activated calcium channel (CLAC channel) |
Synonyms | PNAS-136 UNQ151/PRO177 PNAS-10 hCG_1766418 TMCC4 |
Description | FUNCTION: Calcium-selective channel required to prevent calcium stores from overfilling, thereby playing a key role in calcium homeostasis . In response to endoplasmic reticulum (ER) overloading, assembles into a homotetramer, forming a functional calcium-selective channel, regulating the calcium content in endoplasmic reticulum store . Component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes . The MPT complex takes over after the SEC61 complex: following membrane insertion of the first few transmembrane segments of proteins by the SEC61 complex, the MPT complex occludes the lateral gate of the SEC61 complex to promote insertion of subsequent transmembrane regions . Within the MPT complex, the GEL subcomplex may mediate insertion of transmembrane regions into the membrane . . FUNCTION: Calcium-selective channel required to prevent calcium stores from overfilling. . |
Accessions | ENST00000465705.4 Q9UM00 J3QRB3 ENST00000476143.7 ENST00000481278.5 ENST00000580248.5 J3KTQ7 ENST00000367881.11 [Q9UM00-1] J3KS45 B7Z591 J3QQY2 L8EA41 ENST00000628579.1 ENST00000612311.4 [Q9UM00-3] ENST00000464650.5 A0A0D9SEL8 |